In today’s episode, Ian King speaks with Dan Ives – managing director of the brokerage and advisory firm Wedbush Securities – to discuss Microsoft’s revenues and AI.

Ian Johnston, global pharmaceutical correspondent at the Financial Times, discusses sales of popular weight loss drug ‘Wegvoy’, made by Novo Nordisk – as they say their sales almost quadrupled last year.

And, Ian discusses GSK’s operating profit of £8.8bn for 2023 with strong selling medicines including its HIV and shingles medication.

Articles You May Like

Energy prices fall, consumer confidence, and mergers and acquisitions
Ford, Disney, Costco and more — Jim Cramer provides his updated views on each
Putin critics like Navalny need support from West, says Litvinenko’s widow
Estonia’s weekend warriors: The ‘SAS’ civilians urging Brits to learn how to fight
‘World’s oldest dog’ stripped of Guinness record title